RecruitingPhase 1 / Phase 2NCT07061574
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Sponsor: City of Hope Medical Center
Indianapolis, IN · +10 more sites
Type 2 Diabetes clinical trials in Indianapolis, IN
11 recruiting type 2 diabetes studies with a site in Indianapolis, IN.
RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Indianapolis, IN · +55 more sites
RecruitingPhase 2NCT07783802
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Sponsor: Eli Lilly and Company
Indianapolis, IN · +29 more sites
RecruitingPhase 2NCT07668388
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Indianapolis, IN · +24 more sites
RecruitingPhase 3NCT07743450
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Sponsor: Ascletis Pharma (China) Co., Limited
Evansville, IN · Indianapolis, IN · Valparaiso, IN · +81 more sites
RecruitingPhase 3NCT06739122
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Sponsor: Eli Lilly and Company
Indianapolis, IN · +40 more sites
RecruitingNot applicableNCT07579702
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Sponsor: Insulet Corporation
Indianapolis, IN · +10 more sites
RecruitingPhase not listedNCT06481904
Registry for Stage 2 Type 1 Diabetes
Sponsor: Sanofi
Indianapolis, IN · +36 more sites
RecruitingPhase not listedNCT07360938
Drug Interaction Potential of Pro-Inflammatory Conditions
Sponsor: Indiana University
Indianapolis, IN
Not yet recruitingPhase 3NCT07881458
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Sponsor: Eli Lilly and Company
Indianapolis, IN · +24 more sites
Not yet recruitingNot applicableNCT06783504
Effect Of Percutaneous Electrical Nerve Field Stimulation on Symptom Control/Nervous System Activity in Patients w/Diabetes Types 1/2
Sponsor: Indiana University
Indianapolis, IN
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.